Dossier

World Health Organization promotes new pact against diabetes

On 14 April 2021, the WHO launched a new Global Diabetes Compact (Global Diabetes Compact), which aims to boost efforts to prevent the disease and treat all those in need, coinciding with the one hundred years of the discovery of insulin. The Global Compact is co-sponsored by WHO and the Government of Canada, with support from the University of Toronto.

About half of all adults with type 2 diabetes remain undiagnosed and 50% of people with type 2 diabetes do not receive the insulin they need, putting them at avoidable risk of debilitating and irreversible complications such as premature death, amputations of limbs and loss of vision.

There is a need to increase access to medicines and diagnostic tools for diabetes, particularly insulin, in low- and middle-income countries.

Currently, the insulin market is dominated by three companies (the American Eli Lilly, the Danish Novo Nordisk and the Franco-German Sanofi-Aventis).

Innovation will be a central component of the Compact with a focus on the development and evaluation of low-cost technologies and digital solutions for diabetes care.

The Global Compact will also focus on catalysing progress by setting global coverage targets for diabetes care. A “global price” will quantify the costs and benefits of achieving these new goals.

Médecins Sans Frontières (MSF) welcomed the new deal and stressed the need to accelerate the availability of more sources of guaranteed quality human insulin so that everyone in need can access a vital medicine.

It is the only non-communicable disease for which the risk of dying prematurely is increasing, rather than decreasing.

New strains of COVID-19

Anthony Fauci warned that the best way to combat the variants is to vaccinate as many people as possible soon as possible and continue with the social distancing and the use of chin. “Viruses cannot mutate unless they reproduce”, he added.

(Report in Spanish)

Adult Still’s Disease

Dr. Franco Gustavo Amaro (Argentina)

Adult Still’s disease in an autoinflammatory disease of unknown etiology, there is little data on its incidence and prevalence in the population, although various genetic and environmental factors involved in its genesis have been reported. It is characterized by pharyngitis, high fever, leukocytosis, arthralgias and skin manifestations. It was first described in 1971 by Bywaters in 14 adult patients. The infant form called idiopathic juvenile arthritis was described by George Still in 1897.

(Full text in Spanish)

George Frederic Still (England, paediatrics, 1868-1941)

Hamman syndrome

Dr. Adel Enrique Escobar García (Colombia) 

Louis Hamman (United States, internist, 1877-1946)

Spontaneous pneumomediastinum or spontaneous mediastinal emphysema is uncommon and is characterized by open air in the mediastinum not preceded by chest trauma, surgery, or any other medical procedure. It was first described by Louis Hamman in 1939, which is why it is also known as Hamman syndrome. The treatment is symptomatic and conservative, despite how impactful the images and the associated clinic may be. Evolution is equally favorable, self-limiting and recurrence is rare.

(Full text in Spanish)

Goodpasture syndrome

Dr. Lucas Dolcemelo (Argentina) 

Anthony Fauci warned that the best way to combat the variants is to vaccinate as many people as possible soon as possible and continue with the social distancing and the use of chin. “Viruses cannot mutate unless they reproduce”, he added.

(Report in Spanish)

Entity first recognized by Ernest W. Goodpasture in 1919 in a patient who suffered hemoptysis and acute hematuria after recovering from a flu which has led to investigate its etiopathogenesis and treatment.

It is characterized by triad: alveolar hemorrhage, rapidly progressive glomerulonephritis and formation of glomerular basal antimembrane antibodies (Ac anti-MBG).

It is an autoimmune disease characterized by the linear deposition of basal antimembrane antibodies at the glomerular and alveolar levels, resulting in rapidly progressive alveolar hemorrhage and glomerulonephritis.

Renal biopsy is the primary tool for making the correct diagnosis in lung-kidney syndromes and is a prognostic study.

Despite being a rare disease, it presents a high morbidity and mortality, so it is important to have a high clinical suspicion, an early diagnosis and an adequate and intensive treatment.

(full text and bibliography in Spanish)

Ernest William Goodpasture (United States, pathologist, 1886-1960)

ZIKA, CHIKUNGUNYA AND DENGUE

Dr. Nathalie Nazareth Abreu Francisconi (Venezuela)

Dengue, Zika and Chikungunya are three viral infectious diseases, which can become epidemic, and like Yellow Fever, among other infections, can be transmitted by Aedes aegypti.

Dengue is the most lethal arbovirosis, particularly during the acute phase of the disease. Faced with the doubt of diagnosis between Dengue, Chikungunya or Zika, it is recommended that the patient be treated as a case of Dengue and that a daily follow-up or at least every 48 hours be carried out to detect serious warning signs, especially during the critical phase of the disease (full text in Spanish)

The anamnesis, the cultural food anthropology and the toxic trends

(Text from the books: Dieta y Nutrición en Medicina Interna e Introducción a la Medicina Clínica, de Roberto M. Cataldi Amatriain. Buenos Aires)

To ask well is to know very much (Arabic proverb)

(Texts in Spanish)

The non-communicable diseases and risk factors

(Texts in Spanish)

Reduction in consumption of sugar, salt and saturated fats

(Texts in Spanish)

Top